4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-011065
Director sold 6,000 shares at $65.08 ($390,480)
- Director acquired 6,000 shares (option exercise)
- Director acquired 1,504 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GRIFFIN MICHELLE RENEE Director | 2021-02-14 | Grant or award | +1,504 | 1,504 | D | ||
| GRIFFIN MICHELLE RENEE Director | 2021-02-16 | Option exercise | +6,000 | $7.80 | $46,800 | 7,504 | D |
| GRIFFIN MICHELLE RENEE Director | 2021-02-16 | Sale | −6,000 | $65.08 | $390,480 | 1,504 | D |
| Derivatives | |||||||
| GRIFFIN MICHELLE RENEE Director | 2021-02-14 | Grant or award · Stock Option (Right to Buy) | +3,759 | 3,759 | D | ||
| GRIFFIN MICHELLE RENEE Director | 2021-02-16 | Option exercise · Stock Option (Right to Buy) | −6,000 | 89,000 | D | ||
| Open-market sales · 6,000 sh · avg $65.08 · $390,480 | |||||||
Loading xslF345X03/doc4.xml…